Abstract:We present an unusual case of antiphospholipid syndrome (APS) in a 31-year-old female patient exhibiting neuropsychiatric manifestations, followed by a subsequent thromboembolic stroke. APS is characterized by antiphospholipid antibodies leading to a prothrombotic state and an increased risk of thrombotic events. While the neurological involvement in APS typically presents with thrombotic events, antiphospholipid antibodies may also directly interact with neural tissue, causing immediate pathogenic effects that disrupt normal function. Neuropsychiatric manifestations in APS are rare but have been documented previously, including cases of psychosis and hallucinations. The timely recognition of APS in patients with neuropsychiatric symptoms is crucial for appropriate management and the prevention of further complications. The reported patient displayed aggressive, bizarre, and erratic behavior upon admission to the psychiatric unit, followed by the development of right-sided facial droop and weakness. Imaging studies revealed stenosis and partial occlusion of the left middle cerebral artery (MCA), and a repeat scan showed a known left MCA territory infarct with increasing hypodensity in specific brain regions. Notably, the patient exhibited multiple purpuric ecchymoses on bilateral upper extremities, raising suspicion of a hypercoagulable state. Laboratory investigations detected elevated levels of anticardiolipin IgG and beta-2 glycoprotein 1 IgG, along with a positive antinuclear antibody. The presence of a patent foramen ovale was also confirmed through echocardiography. This case emphasizes the importance of early APS recognition in patients with neuropsychiatric symptoms, facilitating appropriate intervention and improved outcomes. Further research is warranted to elucidate the underlying pathophysiological mechanisms connecting APS to neuropsychiatric manifestations, enabling enhanced understanding and refined management of this intricate condition.

S4751 Splenic infarct and SMA thrombosis as a manifestation of Seronegative Antiphospholipid Syndrome

Antiphospholipid Antibodies and the Antiphospholipid Syndrome: From Coagulation to the Clinic.

Antiphospholipid Syndrome: a Survey of Clinical Characters in Ten Cases

Patterns of Cerebrovascular Accidents in Antiphospholipid Syndrome

Clinical and Laboratory Diagnosis of Antiphospholipid Syndrome: A Review

Seronegative antiphospholipid syndrome: refining the value of “non-criteria” antibodies for diagnosis and clinical management

The Issue of the Antiphospholipid Antibody Syndrome

A case of repeated in-stent restenosis of coronary artery as a primary manifestation of seronegative antiphospholipid antibody syndrome

Elucidating the Neuropsychiatric Phenomena of Antiphospholipid Syndrome in a 31-Year-Old Female

Septal atrial thrombosis as a primary presentation of antiphospholipid syndrome in a patient with ANA-negative systemic lupus erythematosus: a case report

Comparison of clinical and serological features in thrombotic antiphospholipid syndrome patients, with and without associated systemic lupus erythematosus, followed for up to 42 years: A single centre retrospective study

Insights into Molecular Mechanisms and Clinical Manifestations

Antiphospholipid antibodies and antiphospholipid syndrome

Noncriteria antiphospholipid antibodies in antiphospholipid syndrome

Antibody profiles in the mosaic of "seronegative" APS syndrome

The antiphospholipid syndrome: a large elephant with many parts or an elusive chameleon disguised by many colours?

Platelets and Thrombotic Antiphospholipid Syndrome

Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition

Arterial Vasculopathy from Small to Large Vessels in a Neuroradiological Perspective

Rare diagnosis of coexistent antiphospholipid syndrome and systemic lupus erythematosus in a male patient with successful management: a case report

Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations